Jialiang Liang

Jialiang Liang, Ph.D. has a diverse work experience starting in 2017 as a Postdoctoral Associate at the Massachusetts Institute of Technology. From 2019 to 2020, they worked as an Equity Research Associate at Citizens JMP Securities, LLC. Jialiang then moved on to UBS where they held the role of Associate Director from 2020 to 2021. Jialiang joined J.P. Morgan in 2021 and had two roles there: first as an Equity Research Associate from 2021 to 2023, and later as a Vice President from January to September 2023. Currently, Jialiang is a Vice President at AllianceBernstein starting from September 2023.

Jialiang Liang, Ph.D. holds a Doctor of Philosophy (Ph.D.) degree in Biomedical Science, which they obtained from the Icahn School of Medicine at Mount Sinai between 2010 and 2017. Prior to that, they completed their Master of Science (M.S.) degree in Stem Cell Biology at the University of Chinese Academy of Sciences from 2007 to 2010. Jialiang also holds a Bachelor of Science (B.S.) degree in Biology from Xiamen University, where they studied from 2003 to 2007. In addition to their educational background, Jialiang Liang has acquired several certifications, such as the Series 63, Series 86, Series 87, SIE, and the CFA Institute Investment Foundations Certificate, all obtained in 2019 and 2020.